Cfl Pharmaceuticals Limited, a active public limited company, was established on 30 September 1981 in Goa, Goa, India. Engaging in brokerage & trading services within the trade sector, it holds CIN: U24246GA1981PLC000465. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.
Formerly known as Cosme Farma Laboratories Limited. It upholds a compliant status. Employing 12 professional, Its leadership includes Maryann Veronica Menezes (Whole-Time Director), Christine Stephanie Menezes (Whole-Time Director), Brenda Juliette Nazareth Menezes (Director). Past directors included Maryann Veronica Menezes, Christine Stephanie Menezes, Pandharinath Jingu Shet Talaulikar. It holds no open charges and ₹128.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Dempo Towers 5Th Flooredc Patto Plaza Panjim, Goa, Goa, 403001.
U24246GA1981PLC000465
000465
30 September 1981
₹7.50 M
₹7.50 M
Roc Goa
Unlisted
Active
Explore comprehensive insights into Cfl Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maryann Veronica Menezes | Whole-Time Director | 30 Nov 2012 | Current |
| Christine Stephanie Menezes | Whole-Time Director | 10 Apr 2013 | Current |
| Brenda Juliette Nazareth Menezes | Director | 30 Oct 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 06 Sep 2012 | Past |
| Pramod Abcsdd | Managing Director | 06 Nov 2013 | Past |
| Pramod Abcsdd | Director | 22 Aug 2016 | Past |
| Pramod Abcsdd | Director | 15 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cfl Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.69% decrease. The company also saw a substantial fall in profitability, with a 58.48% decrease in profit. The company's net worth moved up by a moderate rise of 2.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Cfl Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,288,286,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2012 | Bank Of India | ₹10.65 Cr | Satisfied |
| 19 May 2009 | Bank Of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank Of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank Of India | ₹3.00 M | Satisfied |
| 16 Mar 2005 | Bank Of India | ₹1.84 M | Satisfied |
Explore comprehensive loan charge details -
Cfl Pharmaceuticals has a workforce of 12 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cfl Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cfl Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cfl Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Cfl Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa. was completed.
Progress on A charge registered on 11 Sep 2007 via Charge ID 10266570 with Bank Of India was fully satisfied on 28 Jan 2015. was documented.
Progress on A charge registered on 16 Mar 2005 via Charge ID 90076512 with Bank Of India was fully satisfied on 28 Jan 2015. was documented.
Progress on A charge registered on 16 Mar 2005 via Charge ID 90075822 with Bank Of India was fully satisfied on 28 Jan 2015. was documented.
A charge registered on 16 Mar 2005 via Charge ID 80006633 with Bank Of India was fully satisfied on 28 Jan 2015. was recorded as a recent event.
The CIN of Cfl Pharmaceuticals Limited is U24246GA1981PLC000465.
Cfl Pharmaceuticals Limited is headquartered at Dempo Towers 5Th Flooredc Patto Plaza Panjim, Goa, Goa, 403001.
Cfl Pharmaceuticals Limited was incorporated on 30 September 1981.
The current directors of Cfl Pharmaceuticals Limited are
The primary industry of Cfl Pharmaceuticals Limited is Trade.
Cfl Pharmaceuticals Limited is unlisted.
The authorized capital of Cfl Pharmaceuticals Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.
The compliance status of Cfl Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX